Showing results (2471-2480 of 3,106) with videos related to
Sort By:
Pageof 311
Expert Review of Anticancer Therapy|September 25, 2015
Pancreatic cancer: BRCA mutation and personalized treatmentGuopei Luo, Yu Lu, Kaizhou Jin, et al.Expert Review of Anticancer Therapy|September 29, 2015
The roles of CD147 in the progression of gliomasFei Fei, Sanzhong Li, Zhou Fei, et al.Expert Review of Anticancer Therapy|January 15, 2015
Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?Juan Martin-Liberal, Oscar M Tirado, Xavier García del MuroExpert Review of Anticancer Therapy|January 26, 2016
Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotinKarlos Z Oregel, Emily Everett, Xinhai Zhang, et al.Expert Review of Anticancer Therapy|November 19, 2015
Nivolumab for the treatment of classical Hodgkin lymphoma after failure of autologous stem cell transplant and brentuximabJose C Villasboas, Stephen M AnsellExpert Review of Anticancer Therapy|November 22, 2015
Pembrolizumab for the treatment of PD-L1 positive advanced or metastatic non-small cell lung cancerThu Oanh Dang, Adebayo Ogunniyi, Meagan S Barbee, et al.Expert Review of Anticancer Therapy|November 22, 2015
Curative therapies for hepatocellular carcinoma: an update and perspectivesRodolfo Sacco, Michela Antonucci, Giampaolo Bresci, et al.Expert Review of Anticancer Therapy|January 20, 2016
External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastomaNeil K Taunk, Fabio Y Moraes, Freddy E Escorcia, et al.Expert Review of Anticancer Therapy|February 4, 2016
Epstein-Barr virus-associated diffuse large B-cell lymphoma: diagnosis, difficulties and therapeutic optionsAna Battle-Lopez, Sonia Gonzalez de Villambrosia, Javier Nuñez, et al.Expert Review of Anticancer Therapy|October 29, 2014
Key papers in prostate cancerSimon Rodney, Taimur Tariq Shah, Hitendra R H Patel, et al.Pageof 311